Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Tucson, Arizona 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
PHASE1, PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
NAINTERVENTIONAL Tucson, Arizona +1 more
RECRUITING
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
PHASE2INTERVENTIONAL Tucson, Arizona
RECRUITING
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
PHASE1, PHASE2INTERVENTIONAL Mesa, Arizona +4 more
RECRUITING
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Arizona Cancer Center Biospecimen Repository
N/AOBSERVATIONAL Tucson, Arizona
RECRUITING
Filter Trials
Trial Phase
Study Type